베타
임상 레이더 AI
임상시험 NCT04310020은(는) 비소세포폐암, 2기 폐암 AJCC v8, 3기 폐암 AJCC v8에 대해 모집중 상태입니다. 모든 세부 정보를 보려면 임상시험 레이더 카드 뷰와 AI 발견 도구를 확인하거나 여기에서 무엇이든 물어보세요.
하나의 임상시험이 필터 기준과 일치합니다.
카드 뷰
검색으로 돌아가기

Study of Radiation Therapy Followed by Atezolizumab in Stage II or III Non-small Cell Lung Cancer Patients

모집중
임상시험 세부 정보는 주로 영어로 제공됩니다. 하지만 임상 레이더 AI가 도와드릴 수 있습니다! '시험 설명하기'를 클릭하여 선택한 언어로 임상시험 정보를 확인하고, 이에 대해 AI와 논의해 보세요.
임상시험 NCT04310020은(는) 치료을(를) 알아보기 위한 연구입니다. 이 연구는 비소세포폐암, 2기 폐암 AJCC v8, 3기 폐암 AJCC v8에 대해 진행되며, 2상 중재연구으로 현재 상태는 모집중입니다. 연구는 2021년 1월 13일에 시작되어 47명의 참여자를 모집하고 있습니다. 미국 국립암연구소이(가) 진행하며, 2026년 9월 1일까지 완료될 예정입니다. ClinicalTrials.gov의 가장 최근 정보는 2025년 10월 30일에 갱신되었습니다.
간단한 개요
This phase II trial studies the side effects of radiation therapy followed by atezolizumab in treating patients with stage II or III non-small cell lung cancer. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more cancer cells and have fewer side effects. Immunotherapy with monoclonal antibodies, such as atezolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The purpose of this study is to test the safety and effectiveness of radiation therapy followed by atezolizumab and find out what side effects, if any, it has on patient's non-small cell lung cancer.
상세한 설명
PRIMARY OBJECTIVE:

I. To evaluate the rate of grade 3-5 treatment-related adverse events (TRAEs) in patients who are not candidates for surgery or concurrent chemoradiation and who have either performance status 0-2 and stage II or performance status 2 and stage III non-small cell lung cancer (NSCLC), treated with hypofractionated thoracic radiotherapy followed by atezolizumab.

SECONDARY OBJECTIVES:

I. To evaluate response rate (confirmed and unconfirmed, complete and partial by Response Evaluation Criteria in Solid Tumors [RECIST] 1.1) from Registration Step 2 in the subset of patients with measurable disease.

II. To evaluate response rate (confirmed and unconfirmed, complete and partial by RECIST 1.1) during radiation therapy in the subset of patients with measurable disease.

III. To evaluate progression free survival (PFS) from Registration Step 2 by RECIST 1.1.

IV. To evaluate overall survival (OS) from Registration Step 2. V. To evaluate the frequency and severity of toxicities.

ADDITIONAL OBJECTIVE:

I. To bank blood and archival tissue for future research.

OUTLINE:

RADIATION THERAPY: Patients undergo hypofractionated radiation therapy 5 days per week over 3 weeks for 15 fractions in the absence of disease progression or unacceptable toxicity.

CONSOLIDATION: Patients receive atezolizumab intravenously (IV) over 30-60 minutes on day 1 of each cycle. Cycles repeat every 21 days for up to 12 months (maximum of 17 cycles) in the absence of disease progression or unacceptable toxicity. Patients undergo computed tomography (CT) scan and may undergo magnetic resonance imaging (MRI) throughout the study, as well as blood sample collection on study.

After completion of study treatment, patients are followed up at 6 weeks, every 12 months for the 1 year, then every 6 months until 3 years after study start.

공식 제목

A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients With Borderline Performance Status

질환/상태
비소세포폐암2기 폐암 AJCC v83기 폐암 AJCC v8
기타 연구 식별자
NCT 번호
NCT04310020
실제 연구 시작일
2021-01-13
최신 업데이트 게시
2025-10-30
예상 연구 완료일
2026-09-01
계획된 등록 인원
47
연구종류
중재연구
단계/상
2상
상태
모집중
주요 목적
치료
설계 할당
해당 없음
중재 모델
단일군설계
맹검 (마스킹)
없음 (공개라벨)
시험군 / 개입
참가자 그룹/시험군개입/치료
실험적Treatment (hypofractionated radiation therapy, atezolizumab)
RADIATION THERAPY: Patients undergo hypofractionated radiation therapy 5 days per week over 3 weeks for 15 fractions in the absence of disease progression or unacceptable toxicity. CONSOLIDATION: Patients receive atezolizumab IV over 30-60 minutes on day 1 of each cycle. Cycles repeat every 21 days for up to 12 months (maximum of 17 cycles) in the absence of disease progression or unacceptable toxicity. Patients undergo CT scan and may undergo MRI throughout the study, as well as blood sample collection on study.
Atezolizumab
Given IV
생체 시료 수집
Undergo blood sample collection
컴퓨터 단층 촬영
Undergo CT scan
저분할 방사선 치료
Undergo hypofractionated radiation therapy
자기 공명 영상
Undergo MRI
주요결과변수
결과변수측정값 설명시간 범위
Rate of grade 3-5 adverse events
Individual toxicities with possible, probable or likely attribution to treatment along with the overall rate of grade 3, 4 or 5 toxicities attributable to treatment will be summarized.
From baseline, until 180 days from Step 2 registration
이차결과변수
결과변수측정값 설명시간 범위
Incidence of adverse events
Individual toxicities with possible, probable or likely attribution to treatment along with the overall rate of grade 3, 4 or 5 toxicities attributable to treatment will be summarized.
Up to 3 years
Response rate (confirmed and unconfirmed, complete and partial by Response Evaluation Criteria in Solid Tumors [RECIST] 1.1) in the subset of patients with measurable disease (Registration Step 2)
Binary endpoints will be summarized as proportions with 95% Clopper-Pearson confidence intervals.
After atezolizumab treatment
Response rate (confirmed and unconfirmed, complete and partial by RECIST 1.1) in the subset of patients with measurable disease (Registration Step 1)
Binary endpoints will be summarized as proportions with 95% Clopper-Pearson confidence intervals.
During radiation therapy
Progression-free survival
Estimated using the method of Kaplan-Meier. 95% confidence for the medians will be constructed using the method of Brookmeyer-Crowley.
From date of Step 2 registration to date of first documentation of progression or symptomatic deterioration, or death due to any cause, assessed up to 3 years
Overall survival
Estimated using the method of Kaplan-Meier. 95% confidence for the medians will be constructed using the method of Brookmeyer-Crowley.
From date of Step 2 registration to date of death due to any cause, assessed up to 3 years
적격성 기준

연령대
성인, 노인
최소 연령
18 Years
참여 가능한 성별
전체
  • REGISTRATION STEP 1: Participants must have pathologic (cytological or histological) proof of non-small cell lung cancer (NSCLC)
  • REGISTRATION STEP 1: Participants must have stage III NSCLC with Zubrod performance status of 2 or stage II NSCLC with Zubrod performance status of 0-2
  • REGISTRATION STEP 1: Participants must not be candidates for surgical resection in the opinion of the treating investigator. Participants whose disease was previously resected must have experienced local or regional recurrence at least 12 months after resection
  • REGISTRATION STEP 1: Participants must not be candidates for concurrent chemoradiation in the opinion of the treating investigator
  • REGISTRATION STEP 1: Participants must have measurable or non-measurable disease documented by CT or MRI. Measurable disease must be assessed within 28 days prior to Registration Step 1. Non-measurable disease must be assessed within 42 days prior to Step 1 registration. The CT from a combined positron emission tomography (PET)/CT may be used only if it is of diagnostic quality. All known sites of disease must be assessed and documented on the Baseline Tumor Assessment Form (RECIST 1.1)
  • REGISTRATION STEP 1: Participants must have an MRI or CT scan of the brain with contrast within 28 days prior to Registration Step 1
  • REGISTRATION STEP 1: Participants' disease must fit within the radiation constraints in the opinion of a local radiation oncologist
  • REGISTRATION STEP 1: Participants may have received prior treatment for their lung cancer, including surgery, chemotherapy, targeted agents, and/or radiation treatment. At least 12 months must have elapsed since last treatment
  • REGISTRATION STEP 1: Participants may have had prior radiation therapy as long as the irradiated area does not overlap with the radiation field targeted for this study
  • REGISTRATION STEP 1: Participants must have recovered from any adverse effects of prior major surgery to the satisfaction of the treating physician. Biopsies and central IV access placement are not considered major surgery
  • REGISTRATION STEP 1: Absolute neutrophil count (ANC) >= 1500/mcl (obtained within 28 days prior to Registration Step 1)
  • REGISTRATION STEP 1: Platelet count >= 100,000/mcl (obtained within 28 days prior to Registration Step 1)
  • REGISTRATION STEP 1: Hemoglobin >= 9 grams/dL (obtained within 28 days prior to Registration Step 1)
  • REGISTRATION STEP 1: Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (obtained within 28 days prior to Registration Step 1)
  • REGISTRATION STEP 1: Aspartate aminotransferase (AST) and alanine aminotransferase (ALT) =< 2.5 x IULN (obtained within 28 days prior to Registration Step 1)
  • REGISTRATION STEP 1: Serum creatinine =< 1.5 x IULN OR measured or calculated creatinine clearance >= 40 mL/min (obtained within 28 days prior to Registration Step 1)
  • REGISTRATION STEP 1: Participants must have percent predicted diffusing capacity of the lungs for carbon monoxide (DLCO) of at least 40% documented within 90 days prior to Registration Step 1
  • REGISTRATION STEP 1: Patient must not have had a prior history of interstitial lung disease or > grade 2 (Common Terminology Criteria for Adverse Events [CTCAE] version 5) pneumonitis
  • REGISTRATION STEP 1: Participants must not have active autoimmune disease requiring therapy within the past 6 months
  • REGISTRATION STEP 1: Participants must not have an active infection requiring therapy
  • REGISTRATION STEP 1: Participants must be ≥ 18 years old
  • REGISTRATION STEP 1: Participants must not be pregnant or nursing because atezolizumab has not been studied in pregnant or nursing women and the mechanism of action is expected to cause fetal harm. Women/men of reproductive potential must have agreed to use an effective contraceptive method while on protocol treatment and for five months after last dose of atezolizumab. A woman is considered to be of "reproductive potential" if she has had menses at any time in the preceding 12 consecutive months. In addition to routine contraceptive methods, "effective contraception" also includes heterosexual celibacy and surgery intended to prevent pregnancy (or with a side-effect of pregnancy prevention) defined as a hysterectomy, bilateral oophorectomy or bilateral tubal ligation. However, if at any point a previously celibate patient chooses to become heterosexually active during the time period for use of contraceptive measures outlined in the protocol, he/she is responsible for beginning contraceptive measures
  • REGISTRATION STEP 1: Participants with known human immunodeficiency virus (HIV) infection must be on effective anti-retroviral therapy and must have undetectable viral load at their most recent viral load test and within 6 months prior to Registration Step 1
  • REGISTRATION STEP 1: Patient must be tested for hepatitis B within 28 days prior to Registration Step 1. Patient must not have active (chronic or acute) hepatitis B virus (HBV) infection. Patients may have past or resolved HBV infection. Active HBV is defined as having a positive hepatitis B surface antigen (HBsAg) test. Past or resolved HBV is defined as having a negative HBsAG test and a positive total hepatitis B core antibody (HBcAb) test
  • REGISTRATION STEP 1: Patients must not have active hepatitis C virus (HCV) infection. Active HCV is defined as having a positive HCV antibody test followed by a positive HCV ribonucleic acid (RNA) test. Patient must have an HCV antibody test within 28 days prior to Registration Step 1. If the HCV antibody test is positive, the patient must also have an HCV quantitative RNA test within 28 days prior to Registration Step 1
  • REGISTRATION STEP 1: No other prior malignancy is allowed except for the following: adequately treated basal cell or squamous cell skin cancer, in situ cervical cancer, adequately treated Stage I or II cancer from which the patient is currently in complete remission, or any other cancer from which the patient has been disease free for three years. Participants with localized prostate cancer who are being followed by an active surveillance program are also eligible
  • REGISTRATION STEP 1: Participants must be offered optional participation in banking of specimens for future research
  • REGISTRATION STEP 1: Participants must be informed of the investigational nature of this study and must sign and give written informed consent in accordance with institutional and federal guidelines
  • REGISTRATION STEP 1: As a part of the Oncology Patient Enrollment Network (OPEN) registration process the treating institution's identity is provided in order to ensure that the current (within 365 days) date of institutional review board approval for this study has been entered in the system
  • REGISTRATION STEP 2: Participants must be registered to Step 2 within 42 days after completion of radiation treatment. Participants must have received at least 44 Gy of radiation treatment
  • REGISTRATION STEP 2: Participants must have no evidence of progression per RECIST 1.1 on CT scan of the chest, abdomen, and pelvis performed between 2 and 5 weeks after completion of radiation therapy
  • REGISTRATION STEP 2: Any toxicities from radiation therapy must have resolved to < grade 2
  • REGISTRATION STEP 2: ANC >= 1.5 x 10^3/uL (obtained within 28 days prior to Registration Step 2)
  • REGISTRATION STEP 2: Platelet count >= 100 x 10^3/uL (obtained within 28 days prior to Registration Step 2)
  • REGISTRATION STEP 2: Hemoglobin >= 9 grams/dL (obtained within 28 days prior to Registration Step 2)
  • REGISTRATION STEP 2: Total bilirubin =< 1.5 x institutional upper limit of normal (IULN) (obtained within 28 days prior to Registration Step 2)
  • REGISTRATION STEP 2: AST and ALT =< 2.5 x IULN (obtained within 28 days prior to Registration Step 2)
  • REGISTRATION STEP 2: Serum creatinine =< 1.5 x IULN OR measured or calculated creatinine clearance >= 40 mL/min (obtained within 28 days prior to Registration Step 2)
  • REGISTRATION STEP 2: Participants must not have received steroids in doses of more than prednisone 10 mg daily or equivalent within 14 days prior to Registration Step 2
  • REGISTRATION STEP 2: Participants must not have received a live vaccine within 28 days prior to Registration Step 2
National Cancer Institute (NCI) logo미국 국립암연구소3028개의 진행 중인 임상시험 탐색 가능
연락처 정보가 없습니다.
172 1개국에 임상시험 장소

Alabama

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, 35233, United States
진행중, 모집종료

Alaska

Anchorage Associates in Radiation Medicine, Anchorage, Alaska, 98508, United States
Site Public Contact, 연락처, 907-212-6871, [email protected]
Charles W. Drescher, 책임연구자
모집중
Alaska Breast Care and Surgery LLC, Anchorage, Alaska, 99508, United States
Site Public Contact, 연락처, 907-212-6871, [email protected]
Charles W. Drescher, 책임연구자
모집중
Alaska Oncology and Hematology LLC, Anchorage, Alaska, 99508, United States
Site Public Contact, 연락처, 907-212-6871, [email protected]
Charles W. Drescher, 책임연구자
모집중
Alaska Women's Cancer Care, Anchorage, Alaska, 99508, United States
Site Public Contact, 연락처, 907-212-6871, [email protected]
Charles W. Drescher, 책임연구자
모집중
Katmai Oncology Group, Anchorage, Alaska, 99508, United States
Site Public Contact, 연락처, 907-212-6871, [email protected]
Charles W. Drescher, 책임연구자
모집중
Providence Alaska Medical Center, Anchorage, Alaska, 99508, United States
Site Public Contact, 연락처, 907-212-6871, [email protected]
Charles W. Drescher, 책임연구자
모집중

Arkansas

NEA Baptist Memorial Hospital and Fowler Family Cancer Center - Jonesboro, Jonesboro, Arkansas, 72401, United States
Site Public Contact, 연락처, 870-936-7066, [email protected]
Sohail A. Minhas, 책임연구자
모집중

California

University of California Davis Comprehensive Cancer Center, Sacramento, California, 95817, United States
진행중, 모집종료

Colorado

AdventHealth Porter, Denver, Colorado, 80210, United States
진행중, 모집종료
AdventHealth Littleton, Littleton, Colorado, 80122, United States
진행중, 모집종료
AdventHealth Parker, Parker, Colorado, 80138, United States
진행중, 모집종료

Florida

Mount Sinai Comprehensive Cancer Center at Aventura, Aventura, Florida, 33180, United States
Site Public Contact, 연락처, 305-674-2625, [email protected]
Debra L. Linzer, 책임연구자
모집중
Mount Sinai Medical Center, Miami Beach, Florida, 33140, United States
Site Public Contact, 연락처, 305-674-2625, [email protected]
Debra L. Linzer, 책임연구자
모집중

Georgia

Augusta University Medical Center, Augusta, Georgia, 30912, United States
Site Public Contact, 연락처, 706-721-2388, [email protected]
Girindra Raval, 책임연구자
모집중
CTCA at Southeastern Regional Medical Center, Newnan, Georgia, 30265, United States
Site Public Contact, 연락처, 770-400-6629
Lily Shakibnia, 책임연구자
모집중

Hawaii

Hawaii Cancer Care Inc - Waterfront Plaza, Honolulu, Hawaii, 96813, United States
진행중, 모집종료
Island Urology, Honolulu, Hawaii, 96813, United States
진행중, 모집종료
Queen's Cancer Cenrer - POB I, Honolulu, Hawaii, 96813, United States
진행중, 모집종료
Queen's Medical Center, Honolulu, Hawaii, 96813, United States
진행중, 모집종료
Straub Clinic and Hospital, Honolulu, Hawaii, 96813, United States
진행중, 모집종료
University of Hawaii Cancer Center, Honolulu, Hawaii, 96813, United States
진행중, 모집종료
Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, 96817, United States
진행중, 모집종료
Queen's Cancer Center - Kuakini, Honolulu, Hawaii, 96817, United States
진행중, 모집종료
The Cancer Center of Hawaii-Liliha, Honolulu, Hawaii, 96817, United States
진행중, 모집종료
Kapiolani Medical Center for Women and Children, Honolulu, Hawaii, 96826, United States
진행중, 모집종료
Wilcox Memorial Hospital and Kauai Medical Clinic, Lihue, Hawaii, 96766, United States
진행중, 모집종료
Hawaii Cancer Care - Westridge, ‘Aiea, Hawaii, 96701, United States
진행중, 모집종료
Pali Momi Medical Center, ‘Aiea, Hawaii, 96701, United States
진행중, 모집종료
Queen's Cancer Center - Pearlridge, ‘Aiea, Hawaii, 96701, United States
진행중, 모집종료
The Cancer Center of Hawaii-Pali Momi, ‘Aiea, Hawaii, 96701, United States
진행중, 모집종료

Idaho

Saint Alphonsus Cancer Care Center-Nampa, Nampa, Idaho, 83687, United States
임시중단

Illinois

Illinois CancerCare-Bloomington, Bloomington, Illinois, 61704, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Canton, Canton, Illinois, 61520, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Carthage, Carthage, Illinois, 62321, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Centralia Oncology Clinic, Centralia, Illinois, 62801, United States
Site Public Contact, 연락처, 217-876-4762, [email protected]
Bryan A. Faller, 책임연구자
모집중
Saint Mary's Hospital, Centralia, Illinois, 62801, United States
임시중단
Jesse Brown Veterans Affairs Medical Center, Chicago, Illinois, 60612, United States
임시중단
University of Illinois, Chicago, Illinois, 60612, United States
Site Public Contact, 연락처, 312-355-3046
Ryan Nguyen, 책임연구자
모집중
Carle at The Riverfront, Danville, Illinois, 61832, United States
Site Public Contact, 연락처, 800-446-5532, [email protected]
Priyank P. Patel, 책임연구자
모집중
Cancer Care Specialists of Illinois - Decatur, Decatur, Illinois, 62526, United States
Site Public Contact, 연락처, 217-876-4762, [email protected]
Bryan A. Faller, 책임연구자
모집중
Decatur Memorial Hospital, Decatur, Illinois, 62526, United States
Site Public Contact, 연락처, 217-876-4762, [email protected]
Bryan A. Faller, 책임연구자
모집중
Carle Physician Group-Effingham, Effingham, Illinois, 62401, United States
Site Public Contact, 연락처, 800-446-5532, [email protected]
Priyank P. Patel, 책임연구자
모집중
Crossroads Cancer Center, Effingham, Illinois, 62401, United States
Site Public Contact, 연락처, 217-876-4762, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Eureka, Eureka, Illinois, 61530, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Galesburg, Galesburg, Illinois, 61401, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Kewanee Clinic, Kewanee, Illinois, 61443, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Macomb, Macomb, Illinois, 61455, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Carle Physician Group-Mattoon/Charleston, Mattoon, Illinois, 61938, United States
Site Public Contact, 연락처, 800-446-5532, [email protected]
Priyank P. Patel, 책임연구자
모집중
Cancer Care Center of O'Fallon, O'Fallon, Illinois, 62269, United States
Site Public Contact, 연락처, 217-876-4762, [email protected]
Bryan A. Faller, 책임연구자
모집중
HSHS Saint Elizabeth's Hospital, O'Fallon, Illinois, 62269, United States
Site Public Contact, 연락처, 217-876-4762, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Ottawa Clinic, Ottawa, Illinois, 61350, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Pekin, Pekin, Illinois, 61554, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Peoria, Peoria, Illinois, 61615, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Methodist Medical Center of Illinois, Peoria, Illinois, 61636, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Peru, Peru, Illinois, 61354, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Illinois CancerCare-Princeton, Princeton, Illinois, 61356, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중
Southern Illinois University School of Medicine, Springfield, Illinois, 62702, United States
Site Public Contact, 연락처, 217-545-7929
Bryan A. Faller, 책임연구자
모집중
Springfield Clinic, Springfield, Illinois, 62702, United States
Site Public Contact, 연락처, 800-444-7541
Bryan A. Faller, 책임연구자
모집중
Springfield Memorial Hospital, Springfield, Illinois, 62781, United States
Site Public Contact, 연락처, 217-528-7541, [email protected]
Bryan A. Faller, 책임연구자
모집중
Carle Cancer Center, Urbana, Illinois, 61801, United States
Site Public Contact, 연락처, 800-446-5532, [email protected]
Priyank P. Patel, 책임연구자
모집중
The Carle Foundation Hospital, Urbana, Illinois, 61801, United States
Site Public Contact, 연락처, 800-446-5532, [email protected]
Priyank P. Patel, 책임연구자
모집중
Illinois CancerCare - Washington, Washington, Illinois, 61571, United States
Site Public Contact, 연락처, 309-243-3605, [email protected]
Bryan A. Faller, 책임연구자
모집중

Iowa

Mary Greeley Medical Center, Ames, Iowa, 50010, United States
Site Public Contact, 연락처, 515-956-4132
Joseph J. Merchant, 책임연구자
모집중
McFarland Clinic - Ames, Ames, Iowa, 50010, United States
Site Public Contact, 연락처, 515-239-4734, [email protected]
Joseph J. Merchant, 책임연구자
모집중
UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny, Iowa, 50023, United States
Site Public Contact, 연락처, 515-241-3305
Richard L. Deming, 책임연구자
모집중
Mercy Cancer Center-West Lakes, Clive, Iowa, 50325, United States
Site Public Contact, 연락처, 515-358-6613, [email protected]
Richard L. Deming, 책임연구자
모집중
UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive, Iowa, 50325, United States
Site Public Contact, 연락처, 515-241-3305
Seema Harichand-Herdt, 책임연구자
모집중
Greater Regional Medical Center, Creston, Iowa, 50801, United States
Site Public Contact, 연락처, 515-358-6613, [email protected]
Richard L. Deming, 책임연구자
모집중
Iowa Methodist Medical Center, Des Moines, Iowa, 50309, United States
Site Public Contact, 연락처, 515-241-6727
Seema Harichand-Herdt, 책임연구자
모집중
UI Health Care Mission Cancer and Blood - Des Moines Clinic, Des Moines, Iowa, 50309, United States
Site Public Contact, 연락처, 515-241-3305
Seema Harichand-Herdt, 책임연구자
모집중
Broadlawns Medical Center, Des Moines, Iowa, 50314, United States
Site Public Contact, 연락처, 515-282-2200
Seema Harichand-Herdt, 책임연구자
모집중
Mercy Medical Center - Des Moines, Des Moines, Iowa, 50314, United States
Site Public Contact, 연락처, 515-358-6613, [email protected]
Richard L. Deming, 책임연구자
모집중
UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines, Iowa, 50314, United States
Site Public Contact, 연락처, 515-241-3305
Seema Harichand-Herdt, 책임연구자
모집중
Iowa Lutheran Hospital, Des Moines, Iowa, 50316, United States
Site Public Contact, 연락처, 515-241-8704
Seema Harichand-Herdt, 책임연구자
모집중
UI Health Care Mission Cancer and Blood - Waukee Clinic, Waukee, Iowa, 50263, United States
Site Public Contact, 연락처, 515-241-3305
Seema Harichand-Herdt, 책임연구자
모집중
Methodist West Hospital, West Des Moines, Iowa, 50266-7700, United States
Site Public Contact, 연락처, 515-343-1000
Seema Harichand-Herdt, 책임연구자
모집중
Mercy Medical Center-West Lakes, West Des Moines, Iowa, 50266, United States
Site Public Contact, 연락처, 515-358-6613, [email protected]
Richard L. Deming, 책임연구자
모집중

Kentucky

Saint Joseph Hospital, Lexington, Kentucky, 40504, United States
진행중, 모집종료
Saint Joseph Radiation Oncology Resource Center, Lexington, Kentucky, 40504, United States
진행중, 모집종료
Saint Joseph Hospital East, Lexington, Kentucky, 40509, United States
진행중, 모집종료

Massachusetts

Beverly Hospital, Beverly, Massachusetts, 01915, United States
Site Public Contact, 연락처, 978-922-3000
Paul J. Hesketh, 책임연구자
모집중
Lahey Hospital and Medical Center, Burlington, Massachusetts, 01805, United States
Site Public Contact, 연락처, 781-744-3421, [email protected]
Paul J. Hesketh, 책임연구자
모집중
Addison Gilbert Hospital, Gloucester, Massachusetts, 01930, United States
Site Public Contact, 연락처, 978-283-4000
Paul J. Hesketh, 책임연구자
모집중
Lahey Medical Center-Peabody, Peabody, Massachusetts, 01960, United States
Site Public Contact, 연락처, 781-744-3421, [email protected]
Paul J. Hesketh, 책임연구자
모집중
Beth Israel Deaconess Medical Center/Winchester Center for Cancer Care, Winchester, Massachusetts, 01890, United States
진행중, 모집종료

Michigan

Henry Ford Health Providence Novi Hospital, Novi, Michigan, 48374, United States
Site Public Contact, 연락처, 248-849-5332, [email protected]
Adam M. Forman, 책임연구자
모집중
Henry Ford Health Providence Southfield Hospital, Southfield, Michigan, 48075, United States
Site Public Contact, 연락처, 248-849-5332, [email protected]
Adam M. Forman, 책임연구자
모집중

Minnesota

Fairview Southdale Hospital, Edina, Minnesota, 55435, United States
Site Public Contact, 연락처, 952-993-1517, [email protected]
David M. King, 책임연구자
모집중
Hennepin County Medical Center, Minneapolis, Minnesota, 55415, United States
Site Public Contact, 연락처, 952-993-1517, [email protected]
David M. King, 책임연구자
모집중
Health Partners Inc, Minneapolis, Minnesota, 55454, United States
Site Public Contact, 연락처, 952-993-1517, [email protected]
David M. King, 책임연구자
모집중
Regions Hospital, Saint Paul, Minnesota, 55101, United States
Site Public Contact, 연락처, 952-993-1517, [email protected]
David M. King, 책임연구자
모집중
Lakeview Hospital, Stillwater, Minnesota, 55082, United States
Site Public Contact, 연락처, 952-993-1517, [email protected]
David M. King, 책임연구자
모집중

Mississippi

Baptist Memorial Hospital and Cancer Center-Desoto, Southhaven, Mississippi, 38671, United States
Site Public Contact, 연락처, 901-226-1366, [email protected]
Sohail A. Minhas, 책임연구자
모집중

Missouri

Saint Francis Medical Center, Cape Girardeau, Missouri, 63703, United States
Site Public Contact, 연락처, 573-334-2230, [email protected]
Bryan A. Faller, 책임연구자
모집중
Parkland Health Center - Farmington, Farmington, Missouri, 63640, United States
Site Public Contact, 연락처, 314-996-5569
Bryan A. Faller, 책임연구자
모집중
Mercy Clinic-Rolla-Cancer and Hematology, Rolla, Missouri, 65401, United States
Site Public Contact, 연락처, 573-458-6379
Jay W. Carlson, 책임연구자
모집중
Phelps Health Delbert Day Cancer Institute, Rolla, Missouri, 65401, United States
Site Public Contact, 연락처, 573-458-7504, [email protected]
Jay W. Carlson, 책임연구자
모집중
Sainte Genevieve County Memorial Hospital, Sainte Genevieve, Missouri, 63670, United States
Site Public Contact, 연락처, 314-996-5569
Bryan A. Faller, 책임연구자
모집중
Mercy Hospital Springfield, Springfield, Missouri, 65804, United States
Site Public Contact, 연락처, 417-269-4520
Jay W. Carlson, 책임연구자
모집중
Missouri Baptist Medical Center, St Louis, Missouri, 63131, United States
Site Public Contact, 연락처, 314-996-5569
Bryan A. Faller, 책임연구자
모집중
Missouri Baptist Sullivan Hospital, Sullivan, Missouri, 63080, United States
Site Public Contact, 연락처, 314-996-5569
Bryan A. Faller, 책임연구자
모집중
BJC Outpatient Center at Sunset Hills, Sunset Hills, Missouri, 63127, United States
Site Public Contact, 연락처, 314-996-5569
Bryan A. Faller, 책임연구자
모집중

Montana

Bozeman Health Deaconess Hospital, Bozeman, Montana, 59715, United States
Site Public Contact, 연락처, 406-969-6060, [email protected]
John M. Schallenkamp, 책임연구자
모집중
Benefis Sletten Cancer Institute, Great Falls, Montana, 59405, United States
Site Public Contact, 연락처, 406-969-6060, [email protected]
John M. Schallenkamp, 책임연구자
모집중
Logan Health Medical Center, Kalispell, Montana, 59901, United States
Site Public Contact, 연락처, 406-969-6060, [email protected]
John M. Schallenkamp, 책임연구자
모집중

New Mexico

University of New Mexico Cancer Center, Albuquerque, New Mexico, 87106, United States
진행중, 모집종료

New York

Montefiore Medical Center-Einstein Campus, The Bronx, New York, 10461, United States
진행중, 모집종료
Montefiore Medical Center-Weiler Hospital, The Bronx, New York, 10461, United States
진행중, 모집종료
Montefiore Medical Center - Moses Campus, The Bronx, New York, 10467, United States
진행중, 모집종료

Ohio

Dayton Physicians LLC-Miami Valley South, Centerville, Ohio, 45459, United States
진행중, 모집종료
Miami Valley Hospital South, Centerville, Ohio, 45459, United States
Site Public Contact, 연락처, 937-528-2900, [email protected]
Tarek M. Sabagh, 책임연구자
모집중
Miami Valley Hospital, Dayton, Ohio, 45409, United States
Site Public Contact, 연락처, 937-528-2900, [email protected]
Tarek M. Sabagh, 책임연구자
모집중
Premier Blood and Cancer Center, Dayton, Ohio, 45409, United States
Site Public Contact, 연락처, 937-276-8320
Tarek M. Sabagh, 책임연구자
모집중
Dayton Physician LLC - Englewood, Dayton, Ohio, 45415, United States
진행중, 모집종료
Miami Valley Hospital North, Dayton, Ohio, 45415, United States
Site Public Contact, 연락처, 937-528-2900, [email protected]
Tarek M. Sabagh, 책임연구자
모집중
Atrium Medical Center-Middletown Regional Hospital, Franklin, Ohio, 45005-1066, United States
Site Public Contact, 연락처, 937-528-2900, [email protected]
Tarek M. Sabagh, 책임연구자
모집중
Miami Valley Cancer Care and Infusion, Greenville, Ohio, 45331, United States
Site Public Contact, 연락처, 937-569-7515
Tarek M. Sabagh, 책임연구자
모집중
Dayton Physicians LLC - Troy, Troy, Ohio, 45373, United States
진행중, 모집종료
Upper Valley Medical Center, Troy, Ohio, 45373, United States
Site Public Contact, 연락처, 937-528-2900, [email protected]
Tarek M. Sabagh, 책임연구자
모집중

Oklahoma

Cancer Centers of Southwest Oklahoma Research, Lawton, Oklahoma, 73505, United States
Site Public Contact, 연락처, 877-231-4440
Raid Aljumaily, 책임연구자
모집중
University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, 73104, United States
Site Public Contact, 연락처, 405-271-8777, [email protected]
Raid Aljumaily, 책임연구자
모집중

Oregon

Clackamas Radiation Oncology Center, Clackamas, Oregon, 97015, United States
Site Public Contact, 연락처, 503-215-2614, [email protected]
Charles W. Drescher, 책임연구자
모집중
Providence Portland Medical Center, Portland, Oregon, 97213, United States
Site Public Contact, 연락처, 503-215-2614, [email protected]
Charles W. Drescher, 책임연구자
모집중
Providence Saint Vincent Medical Center, Portland, Oregon, 97225, United States
Site Public Contact, 연락처, 503-215-2614, [email protected]
Charles W. Drescher, 책임연구자
모집중
Oregon Health and Science University, Portland, Oregon, 97239, United States
진행중, 모집종료

Pennsylvania

UPMC Hillman Cancer Center Erie, Erie, Pennsylvania, 16505, United States
Site Public Contact, 연락처, 412-389-5208, [email protected]
Liza C. Villaruz, 책임연구자
모집중
UPMC Cancer Center at UPMC Horizon, Farrell, Pennsylvania, 16121, United States
Site Public Contact, 연락처, [email protected]
Liza C. Villaruz, 책임연구자
모집중
UPMC Cancer Centers - Arnold Palmer Pavilion, Greensburg, Pennsylvania, 15601, United States
Site Public Contact, 연락처, 724-838-1900
Liza C. Villaruz, 책임연구자
모집중
UPMC Hillman Cancer Center in Greenville/UPMC Horizon, Greenville, Pennsylvania, 16125, United States
Site Public Contact, 연락처, 412-389-5208, [email protected]
Liza C. Villaruz, 책임연구자
모집중
UPMC Cancer Center - Monroeville, Monroeville, Pennsylvania, 15146, United States
Site Public Contact, 연락처, [email protected]
Liza C. Villaruz, 책임연구자
모집중
UPMC Hillman Cancer Center - Monroeville, Monroeville, Pennsylvania, 15146, United States
Site Public Contact, 연락처, 412-389-5208, [email protected]
Liza C. Villaruz, 책임연구자
모집중
UPMC Hillman Cancer Center - New Castle, New Castle, Pennsylvania, 16105, United States
Site Public Contact, 연락처, 412-389-5208, [email protected]
Liza C. Villaruz, 책임연구자
모집중
Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, 19107, United States
철회
UPMC-Saint Margaret, Pittsburgh, Pennsylvania, 15215, United States
Site Public Contact, 연락처, 412-784-4900
Liza C. Villaruz, 책임연구자
모집중
University of Pittsburgh Cancer Institute (UPCI), Pittsburgh, Pennsylvania, 15232, United States
Site Public Contact, 연락처, 412-647-8073
Liza C. Villaruz, 책임연구자
모집중
UPMC-Shadyside Hospital, Pittsburgh, Pennsylvania, 15232, United States
Site Public Contact, 연락처, 412-621-2334
Liza C. Villaruz, 책임연구자
모집중
UPMC-Passavant Hospital, Pittsburgh, Pennsylvania, 15237, United States
Site Public Contact, 연락처, 412-367-6454
Liza C. Villaruz, 책임연구자
모집중
UPMC-Saint Clair Hospital Cancer Center, Pittsburgh, Pennsylvania, 15243, United States
Site Public Contact, 연락처, 412-502-3920
Liza C. Villaruz, 책임연구자
모집중
UPMC Cancer Center at UPMC Northwest, Seneca, Pennsylvania, 16346, United States
Site Public Contact, 연락처, 814-676-7900
Liza C. Villaruz, 책임연구자
모집중
UPMC Cancer Center-Washington, Washington, Pennsylvania, 15301, United States
Site Public Contact, 연락처, [email protected]
Liza C. Villaruz, 책임연구자
모집중
UPMC Washington Hospital Radiation Oncology, Washington, Pennsylvania, 15301, United States
Site Public Contact, 연락처, 724-223-3788, [email protected]
Liza C. Villaruz, 책임연구자
모집중

Tennessee

Baptist Memorial Hospital and Cancer Center-Collierville, Collierville, Tennessee, 38017, United States
Site Public Contact, 연락처, 901-226-1366, [email protected]
Sohail A. Minhas, 책임연구자
모집중
Baptist Memorial Hospital and Cancer Center-Memphis, Memphis, Tennessee, 38120, United States
Site Public Contact, 연락처, 901-226-1366, [email protected]
Sohail A. Minhas, 책임연구자
모집중

Texas

Parkland Memorial Hospital, Dallas, Texas, 75235, United States
진행중, 모집종료
UT Southwestern Simmons Cancer Center - RedBird, Dallas, Texas, 75237, United States
Site Public Contact, 연락처, 214-648-7097, [email protected]
Suzanne M. Cole, 책임연구자
모집중
UT Southwestern/Simmons Cancer Center-Dallas, Dallas, Texas, 75390, United States
진행중, 모집종료
UT Southwestern/Simmons Cancer Center-Fort Worth, Fort Worth, Texas, 76104, United States
진행중, 모집종료
UT Southwestern Clinical Center at Richardson/Plano, Richardson, Texas, 75080, United States
진행중, 모집종료
University of Texas Health Science Center at San Antonio, San Antonio, Texas, 78229, United States
진행중, 모집종료

Washington

Swedish Medical Center-Ballard Campus, Seattle, Washington, 98107, United States
Site Public Contact, 연락처, 206-215-3086, [email protected]
Charles W. Drescher, 책임연구자
모집중
Swedish Medical Center-Cherry Hill, Seattle, Washington, 98122-5711, United States
임시중단
Swedish Medical Center-First Hill, Seattle, Washington, 98122, United States
Site Public Contact, 연락처, 206-215-2343, [email protected]
Charles W. Drescher, 책임연구자
모집중

Wisconsin

Ascension Saint Elizabeth Hospital, Appleton, Wisconsin, 54915, United States
Site Public Contact, 연락처, 414-635-6420, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Ascension Southeast Wisconsin Hospital - Elmbrook Campus, Brookfield, Wisconsin, 53045, United States
Site Public Contact, 연락처, 414-635-6420, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Ascension Calumet Hospital, Chilton, Wisconsin, 53014, United States
Site Public Contact, 연락처, 414-635-6420, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Marshfield Medical Center-EC Cancer Center, Eau Claire, Wisconsin, 54701, United States
Site Public Contact, 연락처, 800-782-8581, [email protected]
David F. Lee, 책임연구자
모집중
Ascension Saint Francis - Reiman Cancer Center, Franklin, Wisconsin, 53132, United States
Site Public Contact, 연락처, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Ascension Southeast Wisconsin Hospital - Franklin, Franklin, Wisconsin, 53132, United States
Site Public Contact, 연락처, 414-635-6420, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Marshfield Medical Center-Marshfield, Marshfield, Wisconsin, 54449, United States
Site Public Contact, 연락처, 800-782-8581, [email protected]
David F. Lee, 책임연구자
모집중
Ascension Columbia Saint Mary's Hospital Ozaukee, Mequon, Wisconsin, 53097, United States
Site Public Contact, 연락처, 414-635-6420, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Ascension Southeast Wisconsin Hospital - Saint Joseph Campus, Milwaukee, Wisconsin, 53210, United States
Site Public Contact, 연락처, 414-635-6420, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Ascension Columbia Saint Mary's Hospital - Milwaukee, Milwaukee, Wisconsin, 53211, United States
Site Public Contact, 연락처, 414-635-6420, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Ascension Saint Francis Hospital, Milwaukee, Wisconsin, 53215, United States
Site Public Contact, 연락처, 414-635-6420, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Marshfield Medical Center - Minocqua, Minocqua, Wisconsin, 54548, United States
Site Public Contact, 연락처, 800-782-8581, [email protected]
David F. Lee, 책임연구자
모집중
Cancer Center of Western Wisconsin, New Richmond, Wisconsin, 54017, United States
Site Public Contact, 연락처, 952-993-1517, [email protected]
David M. King, 책임연구자
모집중
Ascension Mercy Hospital, Oshkosh, Wisconsin, 54904, United States
Site Public Contact, 연락처, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Ascension All Saints Hospital, Racine, Wisconsin, 53405, United States
Site Public Contact, 연락처, 414-635-6420, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Marshfield Medical Center-Rice Lake, Rice Lake, Wisconsin, 54868, United States
Site Public Contact, 연락처, 800-782-8581, [email protected]
David F. Lee, 책임연구자
모집중
Marshfield Medical Center-River Region at Stevens Point, Stevens Point, Wisconsin, 54482, United States
Site Public Contact, 연락처, 800-782-8581, [email protected]
David F. Lee, 책임연구자
모집중
Ascension Medical Group Southeast Wisconsin - Mayfair Road, Wauwatosa, Wisconsin, 53226, United States
Site Public Contact, 연락처, [email protected]
Francis J. Cuevas, 책임연구자
모집중
Marshfield Medical Center - Weston, Weston, Wisconsin, 54476, United States
Site Public Contact, 연락처, 800-782-8581, [email protected]
David F. Lee, 책임연구자
모집중